Fig. 1 · Structure

Documents & Downloads

Cerdulatinib (PRT 062070)

Cat. No. A14147 CAS 1198300-79-6

Dual Syk and JAK inhibitor

PRT062070 is a novel, oral, dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor. Cerdulatinib preferentially inhibited JAK1 and JAK3 dependent cytokine mediated signaling and functional responses in various cell types.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
Tyk2 IC50 0.5 nM
JAK1 IC50 12 nM
JAK2 IC50 6 nM
JAK3 IC50 8 nM
SYK IC50 32 nM
MST1 IC50 4 nM
ARK5 IC50 4 nM
MLK1 IC50 5 nM
FMS IC50 5 nM
AMPK IC50 6 nM
TBK1 IC50 10 nM
MARK1 IC50 10 nM
PAR1B-a IC50 13 nM
TSSK IC50 14 nM
MST2 IC50 15 nM
GCK IC50 18 nM
JNK3 IC50 18 nM
Rsk2 IC50 20 nM
Rsk4 IC50 28 nM
CHK1 IC50 42 nM
Flt4 IC50 51 nM
Flt3 IC50 90 nM
Ret IC50 105 nM
Itk IC50 194 nM

24 targets · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1198300-79-6
Applications Dual Syk and JAK inhibitor
Formula C20H27N7O3S
Molecular Weight 445.54
Synonyms PRT2070; PRT-062070
SMILES
CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...